- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
Prince Pharmaceutical Co., Ltd. EBITDA Margin is 3.00% for the year ending December 31, 2024, a -74.40% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges. Prince Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2023 was 11.71%, a -33.58% change year over year. Prince Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was 17.62%, a 78.83% change year over year. Prince Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 9.86%, a -475.28% change year over year. Prince Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was -2.63%, a 218,402.85% change year over year.
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max